Pharma Hub Resource Capacity Vs Yield (1)

Capacity vs Yields

Increasing capacity and yield are valuable in their own right, yet they’re even more powerful together. Strike the right balance and you’ll achieve the required number of doses and a strong ROI.

Advances in new treatments and high demand from across the world have led to rapid growth in the US biopharmaceutical industry.

In order to meet this demand, manufacturers will be looking to invest in people, equipment and new facilities.

Yet increasing or maximizing capacity is not the only option available to manufacturers.

This whitepaper looks at how increasing capacity and improving yield go hand-in-hand – and how biopharma manufacturers benefit from investment in both.

The topics explored:

  • Weighing up the costs of increasing capacity
  • Better processes, better yields
  • Why manual handling is risky
  • How an APS tool can support better batch yield and increased capacity

Download the whitepaper


A Practical Guide to Scaling Up in Pharma and Biopharma

How pharmaceutical and biopharmaceutical companies can scale up production without impacting other areas of production.
Find out more

Explore further